CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 80 filers reported holding CHEMBIO DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $101,000 | +124.4% | 34,000 | +167.8% | 0.00% | – |
Q1 2021 | $45,000 | -31.8% | 12,696 | -8.8% | 0.00% | – |
Q4 2020 | $66,000 | -4.3% | 13,915 | -2.7% | 0.00% | – |
Q3 2020 | $69,000 | +137.9% | 14,307 | +59.5% | 0.00% | – |
Q2 2020 | $29,000 | -85.9% | 8,969 | -73.4% | 0.00% | – |
Q2 2019 | $205,000 | -47.4% | 33,728 | -52.0% | 0.00% | – |
Q1 2019 | $390,000 | -16.8% | 70,300 | -15.2% | 0.00% | – |
Q4 2018 | $469,000 | -43.8% | 82,935 | +4.3% | 0.00% | – |
Q3 2018 | $834,000 | +89.1% | 79,508 | +99.5% | 0.00% | – |
Q2 2018 | $441,000 | +14600.0% | 39,850 | +7622.9% | 0.00% | – |
Q2 2017 | $3,000 | – | 516 | +426.5% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 98 | -51.0% | 0.00% | – |
Q3 2016 | $1,000 | -99.5% | 200 | -99.1% | 0.00% | – |
Q2 2016 | $187,000 | – | 22,928 | +9335.4% | 0.00% | – |
Q1 2015 | $0 | – | 243 | +523.1% | 0.00% | – |
Q4 2013 | $0 | – | 39 | +3800.0% | 0.00% | – |
Q3 2013 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |